AC   CVCL_M141
SY   SJ-G2; SJG2
DR   Wikidata; Q54953524
RX   PubMed=7634381;
RX   PubMed=9220028;
RX   PubMed=20922763;
CC   Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel.
CC   Doubling time: 29 hours (PubMed=20922763).
ST   Source(s): COG; PubMed=20922763
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 16,17
ST   D19S433: 12,14
ST   D2S1338: 17,24
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 12
ST   D8S1179: 8,12
ST   FGA: 24
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens
SX   Female
AG   4Y2M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 12-03-20; Version: 9
RX   PubMed=7634381; DOI=10.1007/BF00686188;
RA   Houghton P.J., Cheshire P.J., Hallman J.D. II, Lutz L., Friedman H.S.,
RA   Danks M.K., Houghton J.A.;
RT   "Efficacy of topoisomerase I inhibitors, topotecan and irinotecan,
RT   administered at low dose levels in protracted schedules to mice
RT   bearing xenografts of human tumors.";
RL   Cancer Chemother. Pharmacol. 36:393-403(1995).
RX   PubMed=9220028; DOI=10.1016/S0303-7207(97)00080-4;
RA   Sharif T.R., Luo W., Sharif M.;
RT   "Functional expression of bombesin receptor in most adult and
RT   pediatric human glioblastoma cell lines; role in mitogenesis and in
RT   stimulating the mitogen-activated protein kinase pathway.";
RL   Mol. Cell. Endocrinol. 130:119-130(1997).
RX   PubMed=20922763; DOI=10.1002/pbc.22801;
RA   Kang M.H., Smith M.A., Morton C.L., Keshelava N., Houghton P.J.,
RA   Reynolds C.P.;
RT   "National Cancer Institute pediatric preclinical testing program:
RT   model description for in vitro cytotoxicity testing.";
RL   Pediatr. Blood Cancer 56:239-249(2011).